Search clinical trials for: NOV-002

Total 4610 results

Hangzhou GluBio Pharmaceutical Co., Ltd.

Recruiting

A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Non-Hodgkin Lymphoma

China
NexImmune Inc.

Suspended

Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma

Relapsed Refractory Multiple Myeloma

United States
PMG Pharm Co., Ltd

Completed

Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs

Arthritis

Korea, Republic of
Takeda

Completed

Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine

Healthy Participants | Norovirus

United States
University of California, San Diego

Recruiting

The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome

Complex Regional Pain Syndrome

United States
emad gamal ismail

Unknown

Measurement of the Biting Force of Rabid Heat Cured Acrylic Resin Versus Modified Conventional Acrylic

Dental Anxiety

Egypt
Hyundai Pharmaceutical Co., LTD.

Completed

Study To Compare Safety and Pharmacokinetic Properties of Surfolase Capsule and HT-002-01 in Healthy Male Volunteers

Healthy

Korea, Republic of
Zai Lab (Hong Kong), Ltd.
Zai Lab (US) LLC

Not yet recruiting

A Phase 2 Study of ZL-1102 in Patients With Chronic Plaque Psoriasis

Plaque Psoriasis

Australia
Gabather AB
Smerud Medical Research International AS

Completed

Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers (GAB-001)

Safety and Tolerability

Finland
UCB Pharma

Completed

Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects

Healthy

United States
DermBiont, Inc.

Suspended

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis

Onychomycosis

United States
PMG Pharm Co., Ltd

Completed

Drug-Drug Interaction Between PK101-001 and PK101-002

Arthritis

Korea, Republic of
Nacuity Pharmaceuticals, Inc.

Recruiting

NPI-002 Intravitreal Implant for the Delay of Cataract Progression

Cataract

Australia
Shanghai Leadingtac Pharmaceutical Co., Ltd.

Not yet recruiting

A Phase 1 Study of LT-002-158 Intended for the Treatment of Skind Disorder in Healthy Adult Volunteers

Atopic Dermatitis | Healthy Volunteer | Hidradenitis Suppurativa
Altum Pharmaceuticals INC

Unknown

Evaluation of AP-002 in Patients With Solid Tumors

Solid Tumor

United States
Phoenicis Therapeutics

Not yet recruiting

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Dystrophic Epidermolysis Bullosa

United States
Celgene

Completed

A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma (NHL)

Lymphoma, Non-Hodgkin

Japan
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine

Influenza | Flu

China
UCB Celltech
Parexel; Comac Medical; MAC Clinical Research; ARENSIA, Moldova

Completed

Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis

Psoriatic Arthritis

Bulgaria, Moldova, Republic of, United Kingdom
Hillhurst Biopharmaceuticals, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Not yet recruiting

A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)

Anemia, Sickle Cell

United States
Argos Therapeutics

Completed

RNA-Loaded Dendritic Cell Cancer Vaccine

Renal Cell Carcinoma

United States, Canada
Anthera Pharmaceuticals

Completed

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease (PLASMA 2)

Coronary Artery Disease

United States
Takeda

Completed

Bivalent Norovirus Vaccine Study

Gastroenteritis

United States
Celularity Incorporated

Completed

A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy

Peripheral Nervous System Diseases | Diabetic Nephropathies

United States
UCB Biopharma S.P.R.L.

Completed

A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by an Auto-injector in Adult Healthy Volunteer Participants

Healthy Volunteers

United States, Germany
Acorda Therapeutics

Completed

A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults

Smoking

United States
KeraCure

Unknown

Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers (KC-002PT)

Diabetes | Foot Ulcer

United States
Novaliq GmbH

Completed

CyclASol for the Treatment of Moderate to Severe Dry-eye Disease (DED)

Dry Eye Syndromes

United States
Acorda Therapeutics

Completed

Safety and Pharmacokinetics (PK) Study of Single Ascending Doses of CVT-427 (Zolmitriptan Inhalation Powder) In Healthy Adults

Migraine

United States
DermBiont, Inc.

Active, not recruiting

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

Tinea Pedis

United States
Glycovax Pharma Inc.
Government of Canada; JSS Medical Research Inc.; Seppic; Avance Clinical Pty Ltd.

Active, not recruiting

Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults

SARS-CoV-2

Australia
NBE-Therapeutics AG
Cmed Clinical Services

Terminated

NBE-002 in Patients With Advanced Solid Tumors

Triple Negative Breast Cancer | Advanced Solid Tumor | Advanced Cancer

United States
Hillhurst Biopharmaceuticals, Inc.
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Volunteers

Anemia, Sickle Cell

United States
Intuitive Surgical

Completed

A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy

Prostate Cancer

United States
Anthera Pharmaceuticals

Completed

PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease (PLASMA)

Coronary Artery Disease (CAD)

United States, Ukraine
NanoBio Corporation

Completed

Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

Onychomycosis

United States, Canada
University of California, San Diego
California Institute for Regenerative Medicine (CIRM); n-Lorem Foundation

Active, not recruiting

Personalized Antisense Oligonucleotide Therapy for Rare Pediatric Genetic Disease: SCN2A

Genetic Disease

United States
Charite University, Berlin, Germany
Berlin Institute of Health; Federal Agency for Disruptive Innovation - SPRIN-D

Completed

Evaluation of Safety of Contraloid Acetate in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

Germany
Medico's Hirata Inc.

Terminated

Safety and Efficacy of SYM-SV/DS-002 in Patients With Severe Aortic Stenosis

Severe Aortic Stenosis

Japan
D3 Bio (Wuxi) Co., Ltd

Recruiting

Study of D3S-002 as Monotherapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Advanced Solid Tumors With MAPK Pathway Mutations

Australia, China, United States
Ziv Hospital

Unknown

Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients

Multiple Sclerosis

Israel
Tasly Pharmaceutical Group Co., Ltd
Sutro Biopharma, Inc.

Recruiting

A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors

Neoplasm Malignant

China
Atriva Therapeutics GmbH
SGS Life Sciences, a division of SGS Belgium NV

Completed

Phase 1 Study of ATR-002

Influenza

Belgium
Protara Therapeutics

Recruiting

Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer (ADVANCED-1)

Non-muscle Invasive Bladder Cancer

United States
Solvay Pharmaceuticals

Completed

A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 Diabetes

Patients With Type 2 Diabetes

Australia
Odyssey Group International, Inc.
Avance Clinical Pty Ltd.

Recruiting

A First in Human Study of the Safety, Tolerability and Pharmacokinetics of PRV-002 in Healthy Volunteers

Traumatic Brain Injury (TBI)

Australia
CHA Vaccine Institute Co., Ltd.

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine (CVI-HBV-002)

Hepatitis B | Vaccine-Preventable Diseases

Korea, Republic of
Acorda Therapeutics

Completed

A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma

Asthma

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer

Cervical Cancer | Vulvar Cancer

United States
University of Pennsylvania

Terminated

Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)

Severe Clostridium Difficile Infection | Severe-Complicated/Fulminant Clostridium Difficile Infection

United States

3

Subscribe